Checkmate Pharmaceuticals, Inc.: common_shares_outstanding
| Value | {"unit": "shares", "value": 21630572, "concept": "us-gaap:CommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | Checkmate Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0b93a8e8-a8b4-44ff-be7b-09aef45cc6d4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-088386 · Open the official SEC filing →Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001651431/common-shares-outstanding/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0b93a8e8-a8b4-44ff-be7b-09aef45cc6d4
History
- no predecessors — first report